Phase II data presented for enzastaurin as add-on therapy to pemetrexed/cisplatin in NSCLC Oct. 8, 2009
Pharmacokinetics, tolerability of novel bevirimat tablet formulation assessed in HIV patients Oct. 7, 2009
RSS